The African nation just sealed a 10-year deal worth hundreds of millions.
“People are using morphine, the main component of opium, as an analgesic for cancer pain,” Benjamin Cadet, a director at Industrial Hemp Ltd., told All Africa. “Opium is an opioid and more addictive and with side effects, yet cannabidiol from medical marijuana is the best option for such patients.”
“Cancer patients are using CBD illegally,” Cadet continued. “We have the scientists and the technology to do this, but regulations are not in place to allow cannabis drugs manufactured for domestic consumption.”
The deal will secure the production of $100 million worth of weed for Canadian companies. German companies will receive €58 million ($65 million) worth of Ugandan weed.
Uganda’s pot farm, located somewhere in the Kasese District, produces both THC- and CBD-rich varieties of cannabis plants for medical products.
While Ugandan officials figure out how to reconcile their fledgling weed industry with national anti-cannabis laws, Africa is quickly waking up from the nightmare of prohibition.